773 related articles for article (PubMed ID: 16452172)
1. Drusen complement components C3a and C5a promote choroidal neovascularization.
Nozaki M; Raisler BJ; Sakurai E; Sarma JV; Barnum SR; Lambris JD; Chen Y; Zhang K; Ambati BK; Baffi JZ; Ambati J
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2328-33. PubMed ID: 16452172
[TBL] [Abstract][Full Text] [Related]
2. Anaphylatoxin Signaling in Retinal Pigment and Choroidal Endothelial Cells: Characteristics and Relevance to Age-Related Macular Degeneration.
Rohrer B
Adv Exp Med Biol; 2018; 1074():45-51. PubMed ID: 29721926
[TBL] [Abstract][Full Text] [Related]
3. An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice.
Ambati J; Anand A; Fernandez S; Sakurai E; Lynn BC; Kuziel WA; Rollins BJ; Ambati BK
Nat Med; 2003 Nov; 9(11):1390-7. PubMed ID: 14566334
[TBL] [Abstract][Full Text] [Related]
4. miRNA involvement in angiogenesis in age-related macular degeneration.
Wang L; Lee AY; Wigg JP; Peshavariya H; Liu P; Zhang H
J Physiol Biochem; 2016 Dec; 72(4):583-592. PubMed ID: 27349759
[TBL] [Abstract][Full Text] [Related]
5. Connecting the innate and adaptive immune responses in mouse choroidal neovascularization via the anaphylatoxin C5a and γδT-cells.
Coughlin B; Schnabolk G; Joseph K; Raikwar H; Kunchithapautham K; Johnson K; Moore K; Wang Y; Rohrer B
Sci Rep; 2016 Mar; 6():23794. PubMed ID: 27029558
[TBL] [Abstract][Full Text] [Related]
6. Metabolic physiology in age related macular degeneration.
Stefánsson E; Geirsdóttir A; Sigurdsson H
Prog Retin Eye Res; 2011 Jan; 30(1):72-80. PubMed ID: 20951826
[TBL] [Abstract][Full Text] [Related]
7. [Age-related Macular Degeneration in the Japanese].
Yoshimura N
Nippon Ganka Gakkai Zasshi; 2016 Mar; 120(3):163-88; discussion 189. PubMed ID: 27164756
[TBL] [Abstract][Full Text] [Related]
8. Development of gene therapy for treatment of age-related macular degeneration.
Askou AL
Acta Ophthalmol; 2014 Jul; 92 Thesis3():1-38. PubMed ID: 24953666
[TBL] [Abstract][Full Text] [Related]
9. [Molecular mechanism of choroidal neovascularization in age-related macular degeneration].
Yoshida T
Nippon Ganka Gakkai Zasshi; 2007 Nov; 111(11):881-91. PubMed ID: 18051818
[TBL] [Abstract][Full Text] [Related]
10. Anti-complement component 5 antibody targeting MG4 domain inhibits choroidal neovascularization.
Jo DH; Kim JH; Yang W; Kim H; Chang S; Kim D; Chang M; Lee K; Chung J; Kim JH
Oncotarget; 2017 Jul; 8(28):45506-45516. PubMed ID: 28477014
[TBL] [Abstract][Full Text] [Related]
11. A local complement response by RPE causes early-stage macular degeneration.
Fernandez-Godino R; Garland DL; Pierce EA
Hum Mol Genet; 2015 Oct; 24(19):5555-69. PubMed ID: 26199322
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of YAP ameliorates choroidal neovascularization via inhibiting endothelial cell proliferation.
Yan Z; Shi H; Zhu R; Li L; Qin B; Kang L; Chen H; Guan H
Mol Vis; 2018; 24():83-93. PubMed ID: 29422766
[TBL] [Abstract][Full Text] [Related]
13. Macrophage to myofibroblast transition contributes to subretinal fibrosis secondary to neovascular age-related macular degeneration.
Little K; Llorián-Salvador M; Tang M; Du X; Marry S; Chen M; Xu H
J Neuroinflammation; 2020 Nov; 17(1):355. PubMed ID: 33239022
[TBL] [Abstract][Full Text] [Related]
14. Distinct effects of complement and of NLRP3- and non-NLRP3 inflammasomes for choroidal neovascularization.
Malsy J; Alvarado AC; Lamontagne JO; Strittmatter K; Marneros AG
Elife; 2020 Dec; 9():. PubMed ID: 33305736
[TBL] [Abstract][Full Text] [Related]
15. Laser prophylaxis for age-related macular degeneration.
Hsu J; Maguire MG; Fine SL
Can J Ophthalmol; 2005 Jun; 40(3):320-31. PubMed ID: 15947802
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the alternative complement pathway accelerates repair processes in the murine model of choroidal neovascularization.
Parsons N; Annamalai B; Obert E; Schnabolk G; Tomlinson S; Rohrer B
Mol Immunol; 2019 Apr; 108():8-12. PubMed ID: 30763805
[TBL] [Abstract][Full Text] [Related]
17. Age-related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3-year follow-up study.
Silva R; Cachulo ML; Fonseca P; Bernardes R; Nunes S; Vilhena N; Faria de Abreu JR
Ophthalmologica; 2011; 226(3):110-8. PubMed ID: 21822000
[TBL] [Abstract][Full Text] [Related]
18. Complement Activation Products and Cytokines in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular Degeneration.
Kato Y; Oguchi Y; Omori T; Shintake H; Tomita R; Kasai A; Ogasawara M; Sugano Y; Itagaki K; Ojima A; Machida T; Sekine H; Sekiryu T
Invest Ophthalmol Vis Sci; 2020 Nov; 61(13):39. PubMed ID: 33252634
[TBL] [Abstract][Full Text] [Related]
19. Ocular cytomegalovirus latency exacerbates the development of choroidal neovascularization.
Xu J; Liu X; Zhang X; Marshall B; Dong Z; Liu Y; Espinosa-Heidmann DG; Zhang M
J Pathol; 2020 Jun; 251(2):200-212. PubMed ID: 32243583
[TBL] [Abstract][Full Text] [Related]
20. Activator of G-protein signaling 8 is involved in VEGF-induced choroidal neovascularization.
Hayashi H; Mamun AA; Takeyama M; Yamamura A; Zako M; Yagasaki R; Nakahara T; Kamei M; Sato M
Sci Rep; 2019 Feb; 9(1):1560. PubMed ID: 30733465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
